ENB Financial Corp declares fourth-quarter cash dividend
ENB Financial Corp announces a $0.19 cash dividend for Q4 2026, marking a $0.01 increase from the prior quarter, payable on December 15, 2026.
SLM Student Loan Trust 2005-7 faces failed remarketing of notes
SLM Student Loan Trust 2005-7 announces a failed remarketing of its class A-5 notes, requiring noteholders to retain their investments.
Edesa Biotech boosts executive salaries amid growth plans
Edesa Biotech increases salaries for CEO and executives, signaling confidence in future growth and stability in the pharmaceutical preparations industry.
SLM Student Loan Trust 2005-5 Faces Failed Remarketing of Notes
SLM Student Loan Trust 2005-5's class A-5 notes face a failed remarketing, impacting noteholders and highlighting challenges in asset-backed securities.
60 Degrees Pharmaceuticals updates investor presentation
60 Degrees Pharmaceuticals updates its investor presentation, enhancing communication with stakeholders and reflecting its strategic direction in the pharmaceutical sector.
Aptevo Therapeutics reports AML treatment progress with mipletamig
Aptevo Therapeutics announces that ten AML patients advanced to stem cell transplant after treatment with mipletamig, highlighting progress in cancer therapies.
Burke & Herbert Financial Services to Hold Votes Every Three Years
Burke & Herbert Financial Services Corp. will hold advisory votes on executive compensation every three years, despite shareholder preference for annual votes.
Nuveen Global Cities REIT Declares Distributions for Stock
Nuveen Global Cities REIT, Inc. has declared distributions for its common stock, reflecting its ongoing commitment to returning value to shareholders.
Sunbelt Rentals to Hold Annual Say-on-Pay Votes Following Vote
Sunbelt Rentals will conduct annual advisory votes on executive compensation, following a strong shareholder vote in favor of this approach.
Cumberland Pharmaceuticals announces positive Phase 2a trial results
Cumberland Pharmaceuticals reports encouraging Phase 2a trial results for oral ifetroban in systemic sclerosis patients, highlighting safety and tolerability.
Citigroup appoints James Flanagan to Board of Directors
Citigroup Inc. enhances its leadership with the appointment of James Flanagan to its Board of Directors and Audit Committee, emphasizing corporate governance.
Brown & Brown Names New CEO Amid Leadership Transition
Brown & Brown, Inc. has appointed a new CEO following the departure of its former chief executive, signaling a shift in leadership for the insurance firm.
Allspring Multi-Sector Income Fund Changes Fiscal Year End
Allspring Multi-Sector Income Fund shifts its fiscal year end from October 31 to December 31, reflecting a strategic adjustment in financial reporting.
Franklin Covey schedules call for Q4 and fiscal year results
Franklin Covey Co. announces a conference call for its Q4 and fiscal year 2026 results, set for November 4, 2026, emphasizing transparency and engagement.
Trilogy Metals completes 2026 field program, names new VP
Trilogy Metals Inc. announces completion of its 2026 field program and appoints David Thomas as Senior VP of Project Development.
Voyager Therapeutics Names Robin Swartz President, Future CEO
Voyager Therapeutics appoints Robin Swartz as President and future CEO, signaling a leadership shift as the company prepares for key clinical trial results.
Armstrong World Industries Reports Significant Updates in 8-K
Armstrong World Industries provides key updates in a recent 8-K filing, signaling potential changes in strategy and operations within the plastics products industry.
Vertical Data Inc. Announces Investor Presentations Plans
Vertical Data Inc. reveals plans for investor presentations to boost engagement and visibility in the management consulting sector.
Opus Genetics announces departure of Chief Scientific Officer
Opus Genetics, Inc. reports the departure of Dr. Ashwath Jayagopal as Chief Scientific and Development Officer, effective October 19, 2026.
Wrap Technologies Appoints Edward Delatorre to Board
Wrap Technologies, Inc. expands its Board of Directors by appointing Edward Delatorre, increasing the board size to seven members.